These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1361 related articles for article (PubMed ID: 27809834)

  • 1. In vitro inhibitory activities of selected Australian medicinal plant extracts against protein glycation, angiotensin converting enzyme (ACE) and digestive enzymes linked to type II diabetes.
    Deo P; Hewawasam E; Karakoulakis A; Claudie DJ; Nelson R; Simpson BS; Smith NM; Semple SJ
    BMC Complement Altern Med; 2016 Nov; 16(1):435. PubMed ID: 27809834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme inhibitory and antioxidant activities of traditional medicinal plants: potential application in the management of hyperglycemia.
    Gulati V; Harding IH; Palombo EA
    BMC Complement Altern Med; 2012 Jun; 12():77. PubMed ID: 22713130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory Effects of Siegesbeckia orientalis Extracts on Advanced Glycation End Product Formation and Key Enzymes Related to Metabolic Syndrome.
    Hung WC; Ling XH; Chang CC; Hsu HF; Wang SW; Lee YC; Luo C; Lee YT; Houng JY
    Molecules; 2017 Oct; 22(10):. PubMed ID: 29065451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nutritional supplements modulate fluorescent protein-bound advanced glycation endproducts and digestive enzymes related to type 2 diabetes mellitus.
    Koch ER; Deo P
    BMC Complement Altern Med; 2016 Sep; 16(1):338. PubMed ID: 27585435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant and anti-glycation capacities of some medicinal plants and their potential inhibitory against digestive enzymes related to type 2 diabetes mellitus.
    Franco RR; da Silva Carvalho D; de Moura FBR; Justino AB; Silva HCG; Peixoto LG; Espindola FS
    J Ethnopharmacol; 2018 Apr; 215():140-146. PubMed ID: 29274842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soybean phenolic-rich extracts inhibit key-enzymes linked to type 2 diabetes (α-amylase and α-glucosidase) and hypertension (angiotensin I converting enzyme) in vitro.
    Ademiluyi AO; Oboh G
    Exp Toxicol Pathol; 2013 Mar; 65(3):305-9. PubMed ID: 22005499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenolic-rich extracts from selected tropical underutilized legumes inhibit α-amylase, α-glucosidase, and angiotensin I converting enzyme in vitro.
    Ademiluyi AO; Oboh G
    J Basic Clin Physiol Pharmacol; 2012 Jan; 23(1):17-25. PubMed ID: 22865445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentially antidiabetic and antihypertensive compounds identified from Pistacia atlantica leaf extracts by LC fingerprinting.
    Ahmed ZB; Yousfi M; Viaene J; Dejaegher B; Demeyer K; Mangelings D; Vander Heyden Y
    J Pharm Biomed Anal; 2018 Feb; 149():547-556. PubMed ID: 29190580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Rhodiola crenulata and Rhodiola rosea for management of type II diabetes and hypertension.
    Kwon YI; Jang HD; Shetty K
    Asia Pac J Clin Nutr; 2006; 15(3):425-32. PubMed ID: 16837437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory activity on type 2 diabetes and hypertension key-enzymes, and antioxidant capacity of Veronica persica phenolic-rich extracts.
    Sharifi-Rad M; Tayeboon GS; Sharifi-Rad J; Iriti M; Varoni EM; Razazi S
    Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):80-5. PubMed ID: 27262808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory potentials of phenolic-rich extracts from Bridelia ferruginea on two key carbohydrate-metabolizing enzymes and Fe
    Afolabi OB; Oloyede OI; Agunbiade SO
    J Integr Med; 2018 May; 16(3):192-198. PubMed ID: 29706572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidant and Antiglycation Activities of Syzygium paniculatum Gaertn and Inhibition of Digestive Enzymes Relevant to Type 2 Diabetes Mellitus.
    Kim S; Semple SJ; Simpson BS; Deo P
    Plant Foods Hum Nutr; 2020 Dec; 75(4):621-627. PubMed ID: 33009631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for potential α-glucosidase and α-amylase inhibitory constituents from selected Vietnamese plants used to treat type 2 diabetes.
    Trinh BTD; Staerk D; Jäger AK
    J Ethnopharmacol; 2016 Jun; 186():189-195. PubMed ID: 27041401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential of cranberry-based herbal synergies for diabetes and hypertension management.
    Apostolidis E; Kwon YI; Shetty K
    Asia Pac J Clin Nutr; 2006; 15(3):433-41. PubMed ID: 16837438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-diabetic and anti-hypertensive potential of sprouted and solid-state bioprocessed soybean.
    McCue P; Kwon YI; Shetty K
    Asia Pac J Clin Nutr; 2005; 14(2):145-52. PubMed ID: 15927931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of antihyperglycemia and antihypertension potential of native Peruvian fruits using in vitro models.
    Pinto Mda S; Ranilla LG; Apostolidis E; Lajolo FM; Genovese MI; Shetty K
    J Med Food; 2009 Apr; 12(2):278-91. PubMed ID: 19459727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chickpea (Cicer arietinum L.) Lectin Exhibit Inhibition of ACE-I, α-amylase and α-glucosidase Activity.
    Bhagyawant SS; Narvekar DT; Gupta N; Bhadkaria A; Gautam AK; Srivastava N
    Protein Pept Lett; 2019; 26(7):494-501. PubMed ID: 30919768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidative activity and inhibition of key enzymes linked to type-2 diabetes (α-glucosidase and α-amylase) by Khaya senegalensis.
    Ibrahim MA; Koorbanally NA; Islam MS
    Acta Pharm; 2014 Sep; 64(3):311-24. PubMed ID: 25296677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in vitro evaluation of antioxidative activity, α-glucosidase and α-amylase enzyme inhibitory of natural phenolic extracts.
    Djeridane A; Hamdi A; Bensania W; Cheifa K; Lakhdari I; Yousfi M
    Diabetes Metab Syndr; 2015; 9(4):324-31. PubMed ID: 25470628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shaddock peels (Citrus maxima) phenolic extracts inhibit α-amylase, α-glucosidase and angiotensin I-converting enzyme activities: a nutraceutical approach to diabetes management.
    Oboh G; Ademosun AO
    Diabetes Metab Syndr; 2011; 5(3):148-52. PubMed ID: 22813568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 69.